The virus spike receptor has been used to successful generate vaccine candidates for SARS-CoV-2 infections. Furthermore, disruption of the virus interacting with host cells represents a viable options for antiviral development. We will express both the viral spike protein and host ACE2 receptor for development of vaccine and antivirals.
Read More